A timely, accurate diagnosis of joint infection is critical to developing a patient treatment plan. Through our laboratory facility, CD Laboratories, we offer a comprehensive panel of tests to aid in the diagnosis of periprosthetic joint infection (PJI) and native septic arthritis (NSA) with a single joint aspiration. Leveraging a streamlined sample submission process, results are typically available within 24 hours of receipt at laboratory.
* Final patient diagnosis responsibility lies with the
medical professional
Procedures
Application
One Stop Comprehensive Aid in PJI and NSA Diagnosis
Combines common standard of care (SoC) tests with proprietary tests only offered by Zimmer Biomet: Synovasure Alpha Defensin ELISA, Synovasure Microbial Identification*. Test panels are designed specifically for infection type (PJI or NSA*).
*Synovasure Microbial Identification and Synovasure Comprehensive NSA Panel are not available in New York State.
Integrity Assessments on All Specimens
Every specimen is tested for Absorbance at 280 nm (A280) and Red Blood Cell Count to ensure the specimen is not diluted by added fluid (saline or contrast) or blood.
Fulfills Industry-Developed Criteria
Panel includes tests that fulfill MSIS, ICM and EBJIS criteria. 1-3
Easy-to-Read Results Report in 24 Hours
Providers receive an easy-to-read report typically within 24-hours of receipt at CD Laboratories, except culture. Cultures are held for 7 days (14 for shoulder specimens).
Literature
Watch animation
Watch animation
Watch animation
Watch animation
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the instructions for use or contact your local representative; search this website for additional product information. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please visit labeling.zimmerbiomet.com or call 1-800-348-2759, press 4 for 411 Technical Support.
